Unity Biotechnology, Inc. Deferred Tax Assets, Gross
Unity Biotechnology, Inc. had Deferred Tax Assets, Gross of $120.60 million as of 2024-12-31, per its 10-K filed 2025-03-07.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross
us-gaap:DeferredTaxAssetsGross · last filed 2025-03-07
- 2024-12-31: Deferred Tax Assets, Gross $120.60M.
- 2023-12-31: Deferred Tax Assets, Gross $113.78M.
- 2022-12-31: Deferred Tax Assets, Gross $106.02M.
- 2021-12-31: Deferred Tax Assets, Gross $93.10M.
| Period end | Deferred Tax Assets, Gross |
|---|---|
| 2024-12-31 | $120.60M 10-K · filed 2025-03-07 |
| 2023-12-31 | $113.78M 10-K · filed 2025-03-07 |
| 2022-12-31 | $106.02M 10-K · filed 2024-04-15 |
| 2021-12-31 | $93.10M 10-K · filed 2023-03-15 |
| 2020-12-31 | $77.65M 10-K · filed 2022-03-15 |
| 2019-12-31 | $49.78M 10-K · filed 2021-03-23 |
| 2018-12-31 | $37.88M 10-K · filed 2020-03-11 |
| 2017-12-31 | $20.30M 10-K · filed 2019-03-06 |